Back
Agios Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
51
AGIO
Agios Pharmaceuticals
Last Price:
32.91
Seasonality Move:
1.86%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
151.49
Seasonality Move:
23.32%
Buy
51
Agios Pharmaceuticals (AGIO)
is a Buy
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $32.94. The Score for AGIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- AGIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $151.37. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $32.94
The current trend is moderately bullish and AGIO is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $151.37
The current trend is relatively stagnant and ALNY is experiencing slight selling pressure.
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 59.59 | Buy |
| Chaikin Money Flow: | 20359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.12 - 33.08) | Buy |
| Bollinger Bands (100): | (23.58 - 31.54) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 53.47 | Buy |
| Chaikin Money Flow: | -78605 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.97 - 152.93) | Buy |
| Bollinger Bands (100): | (146.02 - 181.8) | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.33 | Sell |
| 20-day SMA: | 31.59 | Buy |
| 50-day SMA: | 30.63 | Buy |
| 200-day SMA: | 25.85 | Buy |
| 8-day EMA: | 32.89 | Buy |
| 20-day EMA: | 31.97 | Buy |
| 50-day EMA: | 30.36 | Buy |
| 200-day EMA: | 27.09 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 150.7 | Buy |
| 20-day SMA: | 147.67 | Buy |
| 50-day SMA: | 149.39 | Buy |
| 200-day SMA: | 170.5 | Sell |
| 8-day EMA: | 150.78 | Buy |
| 20-day EMA: | 149.49 | Buy |
| 50-day EMA: | 152.18 | Sell |
| 200-day EMA: | 168.38 | Sell |
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.88 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
Agios Pharmaceuticals Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||